Inventor
KESHAVARZ-SHOKRI ALI
US34 patents
⚠️ This page may combine multiple inventors who share the name “KESHAVARZ-SHOKRI ALI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
24 patentsUS8846718B2Sep 30, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA77 citations99
US9840499B2Dec 12, 2017
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA41 citations98
US9434717B2Sep 6, 2016
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA53 citations98
US9150552B2Oct 6, 2015
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA58 citations98
US8969574B2Mar 3, 2015
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
VERTEX PHARMA61 citations98
US8742122B2Jun 3, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
VERTEX PHARMA67 citations98
US9051303B2Jun 9, 2015
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamide
VERTEX PHARMA59 citations97
US8802868B2Aug 12, 2014
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
VERTEX PHARMA68 citations97
US9163042B2Oct 20, 2015
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA46 citations96
US10906891B2Feb 2, 2021
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA13 citations94
US10597384B2Mar 24, 2020
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA17 citations94
US10081621B2Sep 25, 2018
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA29 citations94
US10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US10787472B2Sep 29, 2020
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA12 citations93
US10570115B2Feb 25, 2020
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA23 citations93
US10253054B2Apr 9, 2019
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA17 citations93
US9828397B2Nov 28, 2017
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA23 citations93
US9464102B2Oct 11, 2016
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA23 citations92
US11578062B2Feb 14, 2023
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA4 citations85
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11186566B2Nov 30, 2021
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA10 citations84
US12065432B2Aug 20, 2024
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA1 citations73
US11773119B2Oct 3, 2023
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA2 citations72
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
BIOMED VALLEY DISCOVERIES INC
5 patentsUS9676746B2Jun 13, 2017
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC6 citations82
US10183927B2Jan 22, 2019
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC2 citations71
US12187698B2Jan 7, 2025
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations61
US11390600B2Jul 19, 2022
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations61
US10738027B2Aug 11, 2020
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations50
KESHAVARZ-SHOKRI ALI
3 patentsUS8653103B2Feb 18, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI79 citations98
US8507534B2Aug 13, 2013
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI101 citations98
US8507687B2Aug 13, 2013
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI83 citations97